keyword
https://read.qxmd.com/read/38630237/mri-data-analysis-in-malformations-of-cortical-development
#21
JOURNAL ARTICLE
Mariasavina Severino, Domenico Tortora, Marcello Scala
Brain magnetic resonance imaging (MRI) is a noninvasive imaging modality that utilizes powerful magnets and radio waves to generate detailed images of the brain, making it a valuable tool for investigating malformations of cortical development (MCD). Various MRI techniques, including 3D T1-weighted, multiplanar thin-sliced T2-weighted, and 3D fluid-attenuated inversion recovery (FLAIR) sequences, can provide high-resolution images with excellent spatial and contrast resolution, allowing for a detailed visualization of cortical anatomy and abnormalities...
2024: Methods in Molecular Biology
https://read.qxmd.com/read/38630213/italian-guidelines-for-the-management-of-adult-individuals-with-overweight-and-obesity-and-metabolic-comorbidities-that-are-resistant-to-behavioral-treatment
#22
JOURNAL ARTICLE
M Chianelli, L Busetto, R Vettor, B Annibale, A Paoletta, E Papini, A Albanese, M Carabotti, D Casarotto, G De Pergola, O E Disoteo, I Grandone, G Medea, E Nisoli, M Raffaelli, S Schiff, F Vignati, M Cinquini, M Gonzalez-Lorenzo, V A Fittipaldo, S Minozzi, M Monteforte, A C Tralongo, R Novizio, A Persichetti, I Samperi, A Scoppola, G Borretta, M Carruba, M G Carbonelli, M De Luca, S Frontoni, S G Corradini, F Muratori, R Attanasio
AIM: This guideline (GL) is aimed at providing a clinical practice reference for the management of adult patients with overweight or obesity associated with metabolic complications who are resistant to lifestyle modification. METHODS: Surgeons, endocrinologists, gastroenterologists, psychologists, pharmacologists, a general practitioner, a nutritionist, a nurse and a patients' representative acted as multi-disciplinary panel. This GL has been developed following the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach...
April 17, 2024: Journal of Endocrinological Investigation
https://read.qxmd.com/read/38630202/predicting-the-efficacy-of-donepezil-intervention-in-alzheimer-s-disease-patients-using-regional-homogeneity-in-the-inferior-orbitofrontal-cortex
#23
JOURNAL ARTICLE
Min Dai, Zhongwei Guo, Honglian Xia, Hong Zhu, Jiapeng Li, Hongtao Hou, Guizhi Zhao, Xiaozheng Liu
BACKGROUND: Although donepezil is a commonly used drug for treating Alzheimer's disease (AD), the mechanisms by which it affects patients' functional brain activity, and thus modulates clinical symptoms, remain unclear. METHODS: In the present study, we used resting-state functional magnetic resonance imaging (MRI) and regional homogeneity (ReHo) to investigate the effects of donepezil on local brain activity in AD patients. Resting-state functional MRI data were collected from 32 subjects: 16 healthy controls and 16 AD patients...
April 17, 2024: Aging Clinical and Experimental Research
https://read.qxmd.com/read/38630199/population-pharmacokinetics-of-adalimumab-in-juvenile-idiopathic-arthritis-patients-a-retrospective-cohort-study-using-clinical-care-data
#24
JOURNAL ARTICLE
Amara Nassar-Sheikh Rashid, Femke Hooijberg, Sandy C Bergkamp, Mariken P Gruppen, Taco W Kuijpers, Mike Nurmohamed, Theo Rispens, Gertjan Wolbink, J Merlijn van den Berg, Dieneke Schonenberg-Meinema, Ron A A Mathôt
BACKGROUND AND OBJECTIVE: Juvenile idiopathic arthritis (JIA) is a chronic autoimmune disorder that primarily affects the joints in children. Notably, it is known to co-occur with uveitis. Adalimumab, a monoclonal anti-TNF antibody, is effective in treating both conditions. A deeper understanding of the pharmacokinetics (PK) of adalimumab in JIA is crucial to advance in more personalized treatment approaches. The objective of this study is to evaluate the population PK profile of adalimumab in JIA and to explain causes for its variability...
April 17, 2024: Paediatric Drugs
https://read.qxmd.com/read/38630197/the-emerging-emetogenicity-of-trifluridine-tipiracil-tas%C3%A2-102-from-patient-self-reporting-a-multicenter-prospective-observational-study
#25
JOURNAL ARTICLE
Hironori Fujii, Masami Tsuchiya, Daichi Watanabe, Ryo Otsuka, Daisuke Hirate, Katsuyuki Takahashi, Makiko Go, Toshihiro Kudo, Kazuhiro Shimomura, Yosuke Ando, Shinya Tani, Takao Takahashi, Katsuhisa Hayashi, Miki Chin, Naomi Matsunami, Masaya Takahashi, Akiko Hasegawa, Takashi Uchida, Hironobu Hashimoto, Akiko Kubo, Nobuhisa Matsuhashi, Akio Suzuki, Junichi Nishimura, Naoki Inui, Hirotoshi Iihara
BACKGROUND: Trifluridine/tipiracil (TAS-102) is an oral anticancer drug with adequate efficacy in unresectable colorectal cancer, but frequently also induces chemotherapy-induced nausea and vomiting (CINV). To investigate the occurrence of CINV and antiemetic therapy in patients with colorectal cancer treated with TAS-102 (JASCC-CINV 2001). METHODS: We conducted a multicenter, prospective, observational study in patients with colorectal cancer who received TAS-102 without dose reduction for the first time...
April 17, 2024: Supportive Care in Cancer
https://read.qxmd.com/read/38630183/evodiamine-potentiates-cisplatin-induced-cell-death-and-overcomes-cisplatin-resistance-in-non-small-cell-lung-cancer-by-targeting-sox9-%C3%AE-catenin-axis
#26
JOURNAL ARTICLE
Munmun Panda, Stuti Biswal, Bijesh K Biswal
BACKGROUND: In recent decades, phytotherapy has remained as a key therapeutic option for the treatment of various cancers. Evodiamine, an excellent phytocompound from Evodia fructus, exerts anticancer activity in several cancers by modulating drug resistance. However, the role of evodiamine in cisplatin-resistant NSCLC cells is not clear till now. Therefore, we have used evodiamine as a chemosensitizer to overcome cisplatin resistance in NSCLC. METHODS: Here, we looked into SOX9 expression and how it affects the cisplatin sensitivity of cisplatin-resistant NSCLC cells...
April 17, 2024: Molecular Biology Reports
https://read.qxmd.com/read/38630176/co-production-of-metallo-%C3%AE-lactamase-and-oxa-type-%C3%AE-lactamases-in-carbapenem-resistant-acinetobacter-baumannii-clinical-isolates-in-north-east-india
#27
JOURNAL ARTICLE
Shyamalima Saikia, Indrani Gogoi, Amos Oloo, Mohan Sharma, Minakshi Puzari, Pankaj Chetia
Carbapenem-resistant Acinetobacter baumannii poses a significant threat to public health globally, especially due to its ability to produce multiple carbapenemases, leading to treatment challenges. This study aimed to investigate the antibiotic resistance pattern of carbapenem-resistant A. baumannii isolates collected from different clinical settings in North East India, focusing on their genotypic and phenotypic resistance profiles. A total of 172 multidrug-resistant A. baumannii isolates were collected and subjected to antibiotic susceptibility test using the Kirby-Bauer disk diffusion method...
April 17, 2024: World Journal of Microbiology & Biotechnology
https://read.qxmd.com/read/38630156/anti-obesity-potentiality-of-lactiplantibacillus-plantarum-e2_mcckt-isolated-from-a-fermented-beverage-haria-a-high-fat-diet-induced-obese-mice-model-study
#28
JOURNAL ARTICLE
Tridip Kumar Das, Priyanka Kar, Titli Panchali, Amina Khatun, Ananya Dutta, Smita Ghosh, Sudipta Chakrabarti, Shrabani Pradhan, Keshab Chandra Mondal, Kuntal Ghosh
Obesity is a growing epidemic worldwide. Several pharmacologic drugs are being used to treat obesity but these medicines exhibit side effects. To find out the alternatives of these drugs, we aimed to assess the probiotic properties and anti-obesity potentiality of a lactic acid bacterium E2_MCCKT, isolated from a traditional fermented rice beverage, haria. Based on the 16S rRNA sequencing, the bacterium was identified as Lactiplantibacillus plantarum E2_MCCKT. The bacterium exhibited in vitro probiotic activity in terms of high survivability in an acidic environment and 2% bile salt, moderate auto-aggregation, and hydrophobicity...
April 17, 2024: World Journal of Microbiology & Biotechnology
https://read.qxmd.com/read/38630073/-wakefulness-promoting-agents-for-severe-fatigue-to-use-or-not-to-use
#29
JOURNAL ARTICLE
Laura E De Wit, Roeland Vis, Laurien L Teunissen
About 20% of adults experience excessive daytime sleepiness or severe fatigue. Causes include somatic conditions, psychiatric disorders, and medication or drug use. Treatment depends on the underlying cause. If sleepiness persists despite optimal treatment of the underlying condition, exclusion of other causes, and behavioral interventions, wakefulness-promoting agents may be considered. However, no established pharmacological strategy exists for symptomatic treatment. Modafinil and stimulants like methylphenidate may offer some benefit based on experiences with narcolepsy or idiopathic hypersomnia...
April 16, 2024: Nederlands Tijdschrift Voor Geneeskunde
https://read.qxmd.com/read/38630029/integration-of-network-pharmacology-lipidomics-and-transcriptomics-analysis-to-reveal-the-mechanisms-underlying-the-amelioration-of-akt-induced-nonalcoholic-fatty-liver-disease-by-total-flavonoids-in-vine-tea
#30
JOURNAL ARTICLE
Siyu Du, Xin Chen, Rumeng Ren, Li Li, Baohui Zhang, Qi Wang, Yan Meng, Zhenpeng Qiu, Guihong Wang, Guohua Zheng, Junjie Hu
Nonalcoholic fatty liver disease (NAFLD) is the main reason for chronic liver diseases and malignancies. Currently, there is a lack of approved drugs for the prevention or treatment of NAFLD. Vine tea ( Ampelopsis grossedentata ) has been used as a traditional Chinese beverage for centuries. Vine tea carries out several biological activities including the regulation of plasma lipids and blood glucose, hepato-protective function, and anti-tumor activity and contains the highest content of flavonoids. However, the underlying mechanisms of total flavonoids from vine tea (TF) in the attenuation of NAFLD remain unclear...
April 17, 2024: Food & Function
https://read.qxmd.com/read/38630024/a-critical-review-of-the-dextroamphetamine-transdermal-system-for-the-treatment-of-adhd-in-adults-and-pediatric-patients
#31
REVIEW
Ann Childress, Nicolas Vaughn
INTRODUCTION: The dextroamphetamine transdermal system (d-ATS) is a stimulant patch recently approved by the United States (U.S.) Food and Drug Administration for the treatment of attention-deficit/hyperactivity disorder (ADHD). AREAS COVERED: The composition of the d-ATS, pharmacokinetics, and metabolism are presented along with data from dermal trials evaluating the tolerability of patch application at various skin sites. Efficacy and safety data from a laboratory classroom study in children and adolescents including effect sizes are assessed...
May 2024: Expert Review of Neurotherapeutics
https://read.qxmd.com/read/38630010/genomic-landscape-and-clinical-features-of-advanced-thyroid-carcinoma-a-national-database-study-in-japan
#32
JOURNAL ARTICLE
Soji Toda, Yukihiko Hiroshima, Hiroyuki Iwasaki, Katsuhiko Masudo
CONTEXT: The relationship between genomic profile and prognosis of advanced thyroid carcinoma requiring drug therapy has not been reported. OBJECTIVE: To evaluate the treatment period and overall survival time for each genetic alteration in advanced thyroid carcinoma that requires drug therapy. METHODS: We conducted a retrospective observational study using a national database in Japan, which included 552 cases of thyroid carcinoma out of 53,543 patients in the database...
April 17, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38629943/current-and-emerging-pharmacotherapy-for-the-treatment-of-gastroparesis
#33
REVIEW
M Ammar Kalas, Irene Sarosiek, Richard W McCallum
INTRODUCTION: Gastroparesis is a chronic disorder characterized by decreased gastric emptying and presents with nausea, vomiting, and abdominal pain which impacts patients' quality of life greatly. The treatment modalities available for gastroparesis have been expanding over the past 2 decades. Currently there are multiple options available for gastroparesis albeit with only one FDA approved medication until June of 2021. AREAS COVERED: We review the different treatments available for gastroparesis and discuss the recently FDA approved intranasal formulation of metoclopramide...
April 17, 2024: Expert Opinion on Pharmacotherapy
https://read.qxmd.com/read/38629915/protocol-for-a-randomized-controlled-trial-to-evaluate-a-permissive-blood-pressure-target-versus-usual-care-in-critically-ill-children-with-hypotension-pressure
#34
JOURNAL ARTICLE
Robert Darnell, Alanna Brown, Emma Laing, Julia Edwards, David A Harrison, Joseph C Manning, Mark J Peters, Padmanabhan Ramnarayan, Samiran Ray, Zia Sadique, Barnaby R Scholefield, Dermot Shortt, Lamprini Lampro, Carly Au, Kathy M Rowan, Paul Mouncey, David P Inwald
OBJECTIVES: Management of hypotension is a fundamental part of pediatric critical care, with cardiovascular support in the form of fluids or vasoactive drugs offered to every hypotensive child. However, optimal blood pressure (BP) targets are unknown. The PRotocolised Evaluation of PermiSSive BP Targets Versus Usual CaRE (PRESSURE) trial aims to evaluate the clinical and cost-effectiveness of a permissive mean arterial pressure (MAP) target of greater than a fifth centile for age compared with usual care...
April 17, 2024: Pediatric Critical Care Medicine
https://read.qxmd.com/read/38629885/antibacterial-activity-of-corydalis-saxicola-bunting-total-alkaloids-against-porphyromonas-gingivalis-in-vitro
#35
JOURNAL ARTICLE
Wenli Ye, Jiaxuan Wu, Qiaozhi Jiang, Zhiheng Su, Haiqing Liao, Zhenmin Liu, Renchuan Tao, Xiangzhi Yong
Aim: To investigate the antibacterial effects of Corydalis Saxicola bunting total alkaloid (CSBTA) on Porphyromonas gingivalis . Methods: SEM, chemical staining, RT-qPCR and ELISA were used to detect effects of CSBTA on P. gingivalis . Results: CSBTA treatment caused shrinkage and rupture of P. gingivalis morphology, decreased biofilm density and live bacteria in biofilm, as well as reduced mRNA expression of virulence genes hagA , hagB , kgp , rgpA and rgpB of P. gingivalis . Furthermore, NOK cells induced by CSBTA-treated P...
April 17, 2024: Future Microbiology
https://read.qxmd.com/read/38629877/reduced-efficacy-of-glucagon-like-peptide-1-receptor-agonists-therapy-in-people-with-type-1-diabetes-and-genetic-forms-of-obesity
#36
JOURNAL ARTICLE
Matthew P Klein, Halis Kaan Akturk, Janet K Snell-Bergeon, Viral N Shah
BACKGROUND: Once weekly Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) have been shown to improve glycemic outcomes and cause significant weight loss. However, 9% to 27% of individuals have little or no response to these drugs. In this article, we investigated the efficacy of GLP-1 RA therapy among adults with type 1 diabetes and obesity likely related to genetic mutations compared with obesity likely unrelated to genetic mutations. METHODS: In this retrospective study, we compared body weight and glycated hemoglobin (HbA1c) change with the use of GLP-1 RA therapy (including a dual agonist, Tirzepatide) over six months among adults with type 1 diabetes and obesity likely (n = 11, median age 39...
April 17, 2024: Journal of Diabetes Science and Technology
https://read.qxmd.com/read/38629875/employment-of-mastoparan-like-peptides-to-prevent-staphylococcus-aureus-associated-with-bovine-mastitis
#37
JOURNAL ARTICLE
Raquel M Q Orozco, Karen G N Oshiro, Ingrid B Pinto, Danieli F Buccini, Claudiane V Almeida, Valentina Nieto Marin, Camila Maurmann de Souza, Maria L R Macedo, Marlon H Cardoso, Octávio L Franco
Bovine mastitis is a frequent infection in lactating cattle, causing great economic losses. Staphylococcus aureus represents the main etiological agent, which causes recurrent and persistent intramammary infections because conventional antibiotics are ineffective against it. Mastoparan-like peptides are multifunctional molecules with broad antimicrobial potential, constituting an attractive alternative. Nevertheless, their toxicity to host cells has hindered their therapeutic application. Previously, our group engineered three mastoparan-L analogs, namely mastoparan-MO, mastoparan-R1, and [I5 , R8 ] MP, to improve cell selectivity and potential...
April 17, 2024: Journal of Bacteriology
https://read.qxmd.com/read/38629757/a-prospective-cohort-study-exploring-the-effect-of-lenvatinib-planned-drug-holidays-in-treatment-of-differentiated-thyroid-cancer
#38
JOURNAL ARTICLE
Makoto Tahara, Hiroshi Takami, Yasuhiro Ito, Takahiro Okamoto, Iwao Sugitani, Kiminori Sugino, Shunji Takahashi, Hiroshi Takeyama, Hidemitsu Tsutsui, Hisato Hara, Ayako Mitsuma, Hiroyuki Yamashita, Yasuo Ohashi, Tsuneo Imai
Background: Although lenvatinib is the preferred treatment for unresectable radioactive iodine-refractory differentiated thyroid cancer (RR-DTC), this agent exerts considerable toxicities, which can lead to frequent dose interruptions and modifications. The adoption of planned drug holidays has been recently suggested as one means of minimizing or avoiding these severe adverse events. Our retrospective study demonstrated that planned drug holidays appear to be a promising strategy for continuing of lenvatinib...
April 17, 2024: Thyroid: Official Journal of the American Thyroid Association
https://read.qxmd.com/read/38629738/cytisine-eye-drops-for-benzalkonium-chloride-induced-dry-eye-safety-and-efficacy-evaluation
#39
JOURNAL ARTICLE
Zijian Wang, Xixi Song, Yanjun Wei, Xianggen Wu, Ying Jie
This experiment aimed to investigate the feasibility of cytisine (CYT) in treating eye diseases with ocular topical application. An in vitro cytotoxicity test, a hen's egg test-chorioallantoic membrane (HET-CAM), and a mouse eye tolerance test were used to fully reveal the ocular safety profiles of CYT. For the efficacy evaluations, CYT's effects on cell wound healing, against H2 O2 -induced oxidative stress damages on cells, and on benzalkonium chloride (BAC)-induced dry eye disease (DED) in mice were evaluated...
April 17, 2024: Pharmaceutical Development and Technology
https://read.qxmd.com/read/38629735/overcoming-the-blood-brain-tumor-barrier-with-docetaxel-loaded-mesoporous-silica-nanoparticles-for-treatment-of-temozolomide-resistant-glioblastoma
#40
JOURNAL ARTICLE
Tsung-I Hsu, Yi-Ping Chen, Rong-Lin Zhang, Zih-An Chen, Cheng-Hsun Wu, Wen-Chang Chang, Chung-Yuan Mou, Hardy Wai-Hong Chan, Si-Han Wu
While temozolomide (TMZ) has been a cornerstone in the treatment of newly diagnosed glioblastoma (GBM), a significant challenge has been the emergence of resistance to TMZ, which compromises its clinical benefits. Additionally, the nonspecificity of TMZ can lead to detrimental side effects. Although TMZ is capable of penetrating the blood-brain barrier (BBB), our research addresses the need for targeted therapy to circumvent resistance mechanisms and reduce off-target effects. This study introduces the use of PEGylated mesoporous silica nanoparticles (MSN) with octyl group modifications (C8-MSN) as a nanocarrier system for the delivery of docetaxel (DTX), providing a novel approach for treating TMZ-resistant GBM...
April 17, 2024: ACS Applied Materials & Interfaces
keyword
keyword
42643
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.